Aurobindo Pharma soars 2% as USFDA approves Methocarbamol tablets

Methocarbamol in USP, 750 mg is an AB-rated generic equivalent to the reference listed drug (RLD), Robaxin-750 tablets of Auxilium Pharmaceuticals, LLC.

Aug 14, 2020 01:08 IST India Infoline News Service

On Sensex, Aurobindo Pharma has gained by a little over 2% with an intraday high of Rs899.95 per piece in early deals and maintained upside. The performance comes after when the company received final approval from the U.S. Food and Drug Administration (USFDA) for its abbreviated new drug application Methocarbamol Tablets USP, 750 mg.USP, 750 mg.

At around 1.25 PM. Aurobindo stock was trading at Rs890.85 per piece up 1.05% on Sensex.

In a notification on the website, the company said on August 12, Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Methocarbamol Tablets USP, 750 mg.

Methocarbamol in USP, 750 mg is an AB-rated generic equivalent to the reference listed drug (RLD), Robaxin-750 tablets of Auxilium Pharmaceuticals, LLC.

The tablet indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.

Related Story